Hartford Small Cap Growth HLS Fund
Schedule of Investments
September 30, 2022  (Unaudited) 

Shares or Principal Amount   Market Value†
COMMON STOCKS - 96.9%
  Automobiles & Components - 2.2%
   83,893 Fox Factory Holding Corp.* $   6,634,258
   92,450 Patrick Industries, Inc.   4,053,008
   59,873 Thor Industries, Inc.   4,189,913
      14,877,179
  Banks - 2.8%
  455,933 MGIC Investment Corp.   5,845,061
132,605 Synovus Financial Corp. 4,974,014
76,886 Triumph Bancorp, Inc.* 4,178,754
53,788 Western Alliance Bancorp 3,536,023
      18,533,852
  Capital Goods - 12.8%
96,283 Altra Industrial Motion Corp. 3,237,034
71,619 Ameresco, Inc. Class A* 4,761,231
108,644 Applied Industrial Technologies, Inc. 11,166,430
66,003 Armstrong World Industries, Inc. 5,229,418
44,572 Boise Cascade Co. 2,650,251
55,360 Chart Industries, Inc.* 10,205,616
44,367 Curtiss-Wright Corp. 6,174,112
27,399 Herc Holdings, Inc. 2,846,208
78,480 ITT, Inc. 5,127,883
72,293 John Bean Technologies Corp. 6,217,198
119,440 SPX Corp.* 6,595,477
131,318 Stem, Inc.* 1,751,782
294,502 WillScot Mobile Mini Holdings Corp.* 11,877,266
352,219 Zurn Water Solutions Corp. 8,629,366
      86,469,272
  Commercial & Professional Services - 6.8%
91,134 ASGN, Inc.* 8,235,780
31,969 CACI International, Inc. Class A* 8,345,827
71,898 Casella Waste Systems, Inc. Class A* 5,492,288
31,253 Clean Harbors, Inc.* 3,437,205
49,739 Exponent, Inc. 4,360,618
73,697 Insperity, Inc. 7,523,727
94,090 KBR, Inc. 4,066,570
35,444 Tetra Tech, Inc. 4,555,617
      46,017,632
  Consumer Durables & Apparel - 3.2%
112,155 Crocs, Inc.* 7,700,562
20,582 Deckers Outdoor Corp.* 6,434,139
19,792 TopBuild Corp.* 3,261,326
142,069 YETI Holdings, Inc.* 4,051,808
      21,447,835
  Consumer Services - 4.5%
27,238 Churchill Downs, Inc. 5,015,878
113,793 Penn National Gaming, Inc.* 3,130,445
126,344 Texas Roadhouse, Inc. Class A 11,024,777
86,906 Wingstop, Inc. 10,899,751
      30,070,851
  Diversified Financials - 1.4%
141,792 OneMain Holdings, Inc. 4,185,700
97,614 Stifel Financial Corp. 5,067,143
      9,252,843
  Energy - 5.6%
56,494 Chord Energy Corp. 7,726,684
141,367 Helmerich & Payne, Inc. 5,226,338
331,710 Magnolia Oil & Gas Corp. Class A 6,571,175
135,779 Ovintiv, Inc. 6,245,834
99,560 PDC Energy, Inc. 5,753,573
166,616 SM Energy Co. 6,266,428
      37,790,032
Shares or Principal Amount   Market Value†
COMMON STOCKS - 96.9% - (continued)
  Food & Staples Retailing - 0.8%
  118,376 Performance Food Group Co.* $   5,084,249
  Food, Beverage & Tobacco - 3.9%
    9,406 Boston Beer Co., Inc. Class A*   3,044,252
   47,703 Celsius Holdings, Inc.*   4,325,708
   73,682 Freshpet, Inc.*   3,690,731
   40,345 Lancaster Colony Corp.   6,063,047
131,698 Simply Good Foods Co.* 4,213,019
371,411 Sovos Brands, Inc.* 5,288,893
      26,625,650
  Health Care Equipment & Services - 10.4%
24,239 Amedisys, Inc.* 2,346,093
69,411 AtriCure, Inc.* 2,713,970
204,927 Covetrus, Inc.* 4,278,876
92,363 Glaukos Corp.* 4,917,406
114,744 Globus Medical, Inc. Class A* 6,835,300
110,575 Haemonetics Corp.* 8,185,867
138,061 Health Catalyst, Inc.* 1,339,192
64,320 Inari Medical, Inc.* 4,672,205
116,748 Integra LifeSciences Holdings Corp.* 4,945,445
15,349 LHC Group, Inc.* 2,512,017
23,508 ModivCare, Inc.* 2,343,277
48,346 Nevro Corp.* 2,252,924
71,795 Omnicell, Inc.* 6,248,319
207,355 Owens & Minor, Inc. 4,997,256
509,882 R1 RCM, Inc.* 9,448,113
49,297 Tandem Diabetes Care, Inc.* 2,358,861
      70,395,121
  Household & Personal Products - 0.5%
305,247 Beauty Health Co.* 3,598,862
  Insurance - 0.4%
120,829 James River Group Holdings Ltd. 2,756,109
  Materials - 3.5%
285,807 Axalta Coating Systems Ltd.* 6,019,096
86,482 Cabot Corp. 5,525,335
47,205 Ingevity Corp.* 2,862,039
256,565 Livent Corp.* 7,863,717
29,681 Louisiana-Pacific Corp. 1,519,370
      23,789,557
  Media & Entertainment - 1.5%
137,984 Bumble, Inc. Class A* 2,965,276
114,598 Cardlytics, Inc.* 1,077,221
91,353 Ziff Davis, Inc.* 6,255,854
      10,298,351
  Pharmaceuticals, Biotechnology & Life Sciences - 12.6%
193,663 Aclaris Therapeutics, Inc.* 3,048,256
99,852 Apellis Pharmaceuticals, Inc.* 6,819,892
75,599 Blueprint Medicines Corp.* 4,981,218
98,799 Celldex Therapeutics, Inc.* 2,777,240
130,221 Crinetics Pharmaceuticals, Inc.* 2,557,540
96,868 Cytokinetics, Inc.* 4,693,255
38,589 Halozyme Therapeutics, Inc.* 1,525,809
65,227 Harmony Biosciences Holdings, Inc.* 2,888,904
532,717 ImmunoGen, Inc.* 2,546,387
101,959 Inhibrx, Inc.* 1,830,164
100,086 Intra-Cellular Therapies, Inc.* 4,657,002
26,228 Karuna Therapeutics, Inc.* 5,899,464
94,469 Kymera Therapeutics, Inc.* 2,056,590
32,899 Mirati Therapeutics, Inc.* 2,297,666
112,989 Morphic Holding, Inc.* 3,197,589
129,167 Myovant Sciences Ltd.* 2,319,839
 

1

Hartford Small Cap Growth HLS Fund
Schedule of Investments – (continued)
September 30, 2022  (Unaudited) 

Shares or Principal Amount   Market Value†
COMMON STOCKS - 96.9% - (continued)
  Pharmaceuticals, Biotechnology & Life Sciences - 12.6% -
(continued)
  119,776 NanoString Technologies, Inc.* $   1,529,540
   22,293 Neurocrine Biosciences, Inc.*   2,367,740
   77,939 Pacira BioSciences, Inc.*   4,145,575
   85,941 PTC Therapeutics, Inc.*   4,314,238
  133,527 Revolution Medicines, Inc.*   2,633,152
   61,907 Sage Therapeutics, Inc.*   2,424,278
118,269 Stoke Therapeutics, Inc.* 1,518,574
129,299 Syndax Pharmaceuticals, Inc.* 3,107,055
11,717 United Therapeutics Corp.* 2,453,305
119,220 Vaxcyte, Inc.* 2,861,280
98,273 Veracyte, Inc.* 1,631,332
95,625 Zentalis Pharmaceuticals, Inc.* 2,071,237
      85,154,121
  Real Estate - 3.2%
39,014 Agree Realty Corp. REIT 2,636,566
250,552 Essential Properties Realty Trust, Inc. REIT 4,873,237
291,585 Independence Realty Trust, Inc. REIT 4,878,217
156,127 Phillips Edison & Co., Inc. REIT(1) 4,379,362
66,749 Ryman Hospitality Properties, Inc. REIT 4,912,059
      21,679,441
  Retailing - 0.6%
78,598 Ollie's Bargain Outlet Holdings, Inc.* 4,055,657
  Semiconductors & Semiconductor Equipment - 5.1%
87,769 Axcelis Technologies, Inc.* 5,315,291
76,228 Cirrus Logic, Inc.* 5,244,486
88,223 Lattice Semiconductor Corp.* 4,341,454
37,083 MKS Instruments, Inc. 3,064,539
90,856 Power Integrations, Inc. 5,843,858
44,865 Silicon Laboratories, Inc.* 5,538,136
53,057 Synaptics, Inc.* 5,253,173
      34,600,937
  Software & Services - 12.5%
85,941 Alarm.com Holdings, Inc.* 5,574,133
81,110 Blackbaud, Inc.* 3,573,707
56,992 Ceridian HCM Holding, Inc.* 3,184,713
51,429 Concentrix Corp. 5,741,019
43,446 Consensus Cloud Solutions, Inc.* 2,054,996
89,264 DigitalOcean Holdings, Inc.* 3,228,679
40,302 ExlService Holdings, Inc.* 5,938,903
51,784 Five9, Inc.* 3,882,764
42,614 LiveRamp Holdings, Inc.* 773,870
62,427 Manhattan Associates, Inc.* 8,304,664
173,224 Olo, Inc. Class A* 1,368,470
93,021 Perficient, Inc.* 6,048,226
88,651 Rapid7, Inc.* 3,803,128
293,204 Repay Holdings Corp. Class A* 2,070,020
128,143 Shift4 Payments, Inc. Class A* 5,716,459
85,902 Sprout Social, Inc. Class A* 5,212,533
161,818 Varonis Systems, Inc.* 4,291,413
584,647 Verra Mobility Corp. Class A* 8,986,025
60,239 Workiva, Inc. Class A* 4,686,594
      84,440,316
  Technology Hardware & Equipment - 2.6%
74,692 Fabrinet* 7,129,351
64,701 Insight Enterprises, Inc.* 5,332,009
77,822 Lumentum Holdings, Inc.* 5,336,255
      17,797,615
  Total Common Stocks
(cost $581,825,246)
  $ 654,735,482
Shares or Principal Amount   Market Value†
EXCHANGE-TRADED FUNDS - 2.0%
  Other Investment Pools & Funds - 2.0%
   63,899 iShares Russell 2000 Growth ETF (1) $  13,200,894
  Total Exchange-Traded Funds
(cost $13,334,988)
  $ 13,200,894
  Total Long-Term Investments
(Cost $595,160,234)
  $ 667,936,376
SHORT-TERM INVESTMENTS - 1.5%
  Repurchase Agreements - 1.1%
$   7,529,118 Fixed Income Clearing Corp. Repurchase Agreement dated 09/30/2022 at 2.950%, due on 10/03/2022 with a maturity value of $7,530,969; collateralized by U.S. Treasury Note at 0.875%, maturing 11/15/2030, with a market value of $7,679,745 $   7,529,118
  Securities Lending Collateral - 0.4%
  416,303 Goldman Sachs Financial Square Funds, Government Fund, Institutional Class, 2.91%(2)      416,303
1,387,678 HSBC US Government Money Market Fund, 2.91%(2) 1,387,678
416,303 Invesco Government & Agency Portfolio, Institutional Class, 2.95%(2) 416,303
416,303 Morgan Stanley Institutional Liquidity Funds, Government Portfolio, Institutional Class, 2.81%(2) 416,303
      2,636,587
  Total Short-Term Investments
(cost $10,165,705)
$ 10,165,705
  Total Investments
(cost $605,325,939)
100.4% $ 678,102,081
  Other Assets and Liabilities (0.4)% (2,610,507)
  Total Net Assets 100.0% $ 675,491,574
Note: Percentage of investments as shown is the ratio of the total market value to total net assets.
  Equity industry classifications used in this report are the Global Industry Classification Standard, which was developed by and is the exclusive property and service mark of MSCI, Inc. and Standard & Poor’s.
  For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.
  See "Glossary" for abbreviation descriptions.
    
* Non-income producing.
(1) Represents entire or partial securities on loan.
(2) Current yield as of period end.
For information regarding the Fund’s significant accounting policies, please refer to the Fund’s most recent shareholder report.
 

2

Hartford Small Cap Growth HLS Fund
Schedule of Investments – (continued)
September 30, 2022  (Unaudited) 

Fair Value Summary
The following is a summary of the fair valuations according to the inputs used as of September 30, 2022 in valuing the Fund’s investments.
Description   Total   Level 1   Level 2   Level 3(1)
Assets                
Common Stocks                
Automobiles & Components   $ 14,877,179   $ 14,877,179   $ —   $ —
Banks   18,533,852   18,533,852    
Capital Goods   86,469,272   86,469,272    
Commercial & Professional Services   46,017,632   46,017,632    
Consumer Durables & Apparel   21,447,835   21,447,835    
Consumer Services   30,070,851   30,070,851    
Diversified Financials   9,252,843   9,252,843    
Energy   37,790,032   37,790,032    
Food & Staples Retailing   5,084,249   5,084,249    
Food, Beverage & Tobacco   26,625,650   26,625,650    
Health Care Equipment & Services   70,395,121   70,395,121    
Household & Personal Products   3,598,862   3,598,862    
Insurance   2,756,109   2,756,109    
Materials   23,789,557   23,789,557    
Media & Entertainment   10,298,351   10,298,351    
Pharmaceuticals, Biotechnology & Life Sciences   85,154,121   85,154,121    
Real Estate   21,679,441   21,679,441    
Retailing   4,055,657   4,055,657    
Semiconductors & Semiconductor Equipment   34,600,937   34,600,937    
Software & Services   84,440,316   84,440,316    
Technology Hardware & Equipment   17,797,615   17,797,615    
Exchange-Traded Funds   13,200,894   13,200,894    
Short-Term Investments   10,165,705   2,636,587   7,529,118  
Total   $ 678,102,081   $ 670,572,963   $ 7,529,118   $ —
    
(1) For the period ended September 30, 2022, there were no transfers in and out of Level 3.

3

Hartford HLS Series Fund II, Inc. (the "Company")
GLOSSARY: (abbreviations used in preceding Schedule of Investments) (Unaudited)

Other Abbreviations:
ETF Exchange-Traded Fund
REIT Real Estate Investment Trust

4

Hartford HLS Series Fund II, Inc. (the "Company")
 Notes to the Schedule of Investments
 September 30, 2022  (Unaudited)

1. Investment Valuation and Fair Value Measurements:
  For purposes of calculating the net asset value per share ("NAV") of each class of the Fund, portfolio securities and other assets held in the Fund's portfolio for which market prices are readily available are valued at market value. Market value is generally determined on the basis of official close price or last reported trade price. If no trades were reported, market value is based on prices obtained from a quotation reporting system, established market makers (including evaluated prices), or independent pricing services. Pricing vendors may use matrix pricing or valuation models that utilize certain inputs and assumptions to derive values, including transaction data, credit quality information, general market conditions, news, and other factors and assumptions.
  With respect to the Fund's investments that do not have readily available market prices, the Company's Board of Directors (the "Board") has designated Hartford Funds Management Company, LLC (the "Investment Manager") as its valuation designee to perform fair valuations pursuant to Rule 2a-5 under the 1940 Act (the "Valuation Designee").
  If market prices are not readily available or deemed unreliable, the Valuation Designee will use the fair value of the security or other instrument as determined in good faith under policies and procedures established by and under the supervision of the Board ("Valuation Procedures").
  The Valuation Designee has delegated the day-to-day responsibility for implementing the Valuation Procedures to the Valuation Committee. The Valuation Committee will consider all available relevant factors in determining an investment’s fair value. The Valuation Designee reports fair value matters to the Audit Committee of the Board.
  Prices of foreign equities that are principally traded on certain foreign markets will generally be adjusted daily pursuant to a fair value pricing service in order to reflect an adjustment for the factors occurring after the close of certain foreign markets but before the NYSE Close. Securities and other instruments that are primarily traded on foreign markets may trade on days that are not business days of the Fund. The value of the foreign securities or other instruments in which the Fund invests may change on days when a shareholder will not be able to purchase or redeem shares of the Fund.
  Fixed income investments (other than short-term obligations) held by the Fund are normally valued at prices supplied by independent pricing services in accordance with the Valuation Procedures. Short-term investments maturing in 60 days or less are generally valued at amortized cost, which approximates fair value.
  Exchange-traded derivatives, such as options, futures and options on futures, are valued at the last sale price determined by the exchange where such instruments principally trade as of the close of such exchange ("Exchange Close"). If a last sale price is not available, the value will be the mean of the most recently quoted bid and ask prices as of the Exchange Close. If a mean of the bid and ask prices cannot be calculated for the day, the value will be the most recently quoted bid price as of the Exchange Close. Over-the-counter derivatives are normally valued based on prices supplied by independent pricing services in accordance with the Valuation Procedures.
  Investments valued in currencies other than U.S. dollars are converted to U.S. dollars using the prevailing spot exchange rates obtained from independent pricing services for calculation of the NAV. As a result, the NAV of the Fund’s shares may be affected by changes in the value of currencies in relation to the U.S. dollar. The value of securities or other instruments traded in markets outside the United States or denominated in currencies other than the U.S. dollar may be affected significantly on a day that the Exchange is closed and the market value may change on days when an investor is not able to purchase, redeem or exchange shares of the Fund.
  Foreign currency contracts represent agreements to exchange currencies on specific future dates at predetermined rates. Foreign currency contracts are valued using foreign currency exchange rates and forward rates as provided by an independent pricing service on the Valuation Date.
  Shares of investment companies listed and traded on an exchange are valued in the same manner as any exchange-listed equity security. Investments in investment companies that are not listed or traded on an exchange ("Non-Traded Funds"), if any, are valued at the respective NAV of each Non-Traded Fund on the Valuation Date. Such Non-Traded Funds and listed investment companies may use fair value pricing as disclosed in their prospectuses.
  Financial instruments for which prices are not available from an independent pricing service may be valued using quotations obtained from one or more dealers that make markets in the respective financial instrument in accordance with the Valuation Procedures.
  U.S. Generally Accepted Accounting Principles ("U.S. GAAP") defines fair value as the price that the Fund would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants. The U.S. GAAP fair value measurement standards require disclosure of a fair value hierarchy for each major category of assets and liabilities. Various inputs are used in determining the fair value of the Fund’s investments. These inputs are summarized into three broad hierarchy levels. This hierarchy is based on whether the valuation inputs are observable or unobservable.

5

Hartford HLS Series Fund II, Inc. (the "Company")
 Notes to the Schedule of Investments – (continued)
 September 30, 2022  (Unaudited)

  These levels are:
  Level 1 – Quoted prices in active markets for identical investments. Level 1 may include exchange-traded instruments, such as domestic equities, some foreign equities, options, futures, mutual funds, exchange-traded funds, rights and warrants.
  Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar investments; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. Level 2 may include debt investments that are traded less frequently than exchange-traded instruments and which are valued using independent pricing services; foreign equities, which are principally traded on certain foreign markets and are adjusted daily pursuant to a fair value pricing service in order to reflect an adjustment for the factors occurring after the close of certain foreign markets but before the NYSE Close; senior floating rate interests, which are valued using an aggregate of dealer bids; short-term investments, which are valued at amortized cost; and swaps, which are valued based upon the terms of each swap contract.
  Level 3 – Significant unobservable inputs that are supported by limited or no market activity. Level 3 may include financial instruments whose values are determined using indicative market quotes or require significant management judgment or estimation. These unobservable valuation inputs may include estimates for current yields, maturity/duration, prepayment speed, and indicative market quotes for comparable investments along with other assumptions relating to credit quality, collateral value, complexity of the investment structure, general market conditions and liquidity. This category may include investments where trading has been halted or there are certain restrictions on trading. While these investments are priced using unobservable inputs, the valuation of these investments reflects the best available data and management believes the prices are a reasonable representation of exit price.
  Valuation levels are not necessarily indicative of the risk associated with investing in such investments. Individual investments within any of the above mentioned asset classes may be assigned a different hierarchical level than those presented above, as individual circumstances dictate.
  For additional information, refer to the Fair Value Summary and the Level 3 roll-forward reconciliation, if applicable, which follows the Fund’s Schedule of Investments.

6